Ozempic and metformin share a number of similarities, and like any drug they come with the risk of some side effects ...

PharmaGiant.com bridges the affordability gap by connecting U.S. patients with licensed Canadian pharmacies, where regulated pricing ensures accessibility. The introduction of generic Semaglutide ...

Researchers have hailed the results of a new study on a once-a-day weight loss pill as an “important advancement” in type 2 diabetes care. A new study compared the medication, named orforglipron, ...

The acquisition of CarepathRX adds to Cigna's ever-growing push for vertical integration and greater control over the flow of pharmaceuticals through the U.S. health care system. Plus: Novartis ...

An investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist, orforglipron (Eli Lilly), demonstrated superior ...

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage—not by controlling blood sugar as originally ...

Our Bureau, Mumbai Saturday, February 28, 2026, 09:00 Hrs [IST] ...

Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

About one in eight U.S. adults are currently taking a GLP-1 drug such as Ozempic, Wegovy, or Zepbound to treat diabetes, ...